A closed-end management investment company focused on investing in equity securities of companies in the healthcare sector. BlackRock Health Sciences Trust II (BMEZ) provides investors with exposure to biotech, pharmaceuticals, and medical device companies, making it a key vehicle for healthcare sector exposure.
1 member of Congress has disclosed 1 trade in BlackRock Health Sciences Trust II (BMEZ), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-01-29 | John Hoeven | buy | $100K – $250K |